Should you buy NVO stock?

Last updated:

Based on market data through , StockInvest.us rates Novo Nordisk A/S (NVO) as a Sell Candidate with a technical score of -3.17 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 1.38%
  • 3-month trend forecast Up 11.84%
  • Sell Candidate -3.17
AI Analysis AI Analysis of NVO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NVO to Watchlist?
Some Reasons Why To Add NVO:
  • High gross margin of 80.6%
  • Strong operating margin of 43.1%
  • Healthy interest coverage ratio of 86.9x
PDF

Novo Nordisk A/S stock price up 0.99% on Monday
(Market data through Aug 10, 2026)

Sell candidate since Jul 31, 2026 Gain 1.38%

The Novo Nordisk A/S stock price gained 0.99% on the last trading day (Monday, 10th Aug 2026), rising from $47.26 to $47.73. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.30% from a day low at $46.66 to a day high of $47.74. The price has risen in 8 of the last 10 days but is still down by -3.91% for this period. Volume fell on the last day by -3 million shares and in total, 9 million shares were bought and sold for approximately $444.74 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.84% during the next 3 months and, with a 90% probability hold a price between $49.92 and $58.42 at the end of this 3-month period.

NVO Signals & Forecast

There are mixed signals in the stock today. The Novo Nordisk A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $48.59. On a fall, the stock will find some support from the short-term average at $46.28. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Tuesday, August 04, 2026, and so far it has risen 7.79%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $47.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.08 between high and low, or 2.30%. For the last week, the stock has had daily average volatility of 4.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVO) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Novo Nordisk A/S to open at $47.38, and during the day (based on 14 day Average True Range), to move between $46.89 and $48.57, which gives a possible trading interval of +/-$1.67 (+/-3.57%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 3.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $48.07 (0.71%) than the support at $47.08 (1.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novo Nordisk A/S stock A Buy?

Novo Nordisk A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.169 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $47.38 ( 0.744%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NVO Performance

Trading levels for NVO

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 48.45 1.51%
R2 48.04 0.648%
R1 47.79 0.117%
Price 47.73
S1 46.96 -1.60%
S2 46.71 -2.14%
S3 46.30 -3.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 49.26 3.21%
R2 48.77 2.18%
R1 48.07 0.712%
Price 47.73
S1 47.08 -1.36%
S2 44.53 -6.70%
S3 44.28 -7.23%

NVO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 04, 2026 Mar 30, 2026 Apr 08, 2026 $0.92 1.92%
2 Sep 18, 2025 Sep 18, 2025 Sep 29, 2025 $0.0038 0.0067%
3 Aug 18, 2025 Aug 18, 2025 Aug 26, 2025 $0.412 0.84%
4 Feb 05, 2025 Mar 31, 2025 Apr 08, 2025 $0.787 1.28%
5 Aug 16, 2024 Aug 16, 2024 Aug 26, 2024 $0.374 0.277%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NVO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Novo Nordisk A/S Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Novo Nordisk A/S (NVO) as a Sell Candidate with a technical score of -3.17 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 31, 2026, the price has risen 1.38%. The current 3-month trend forecast projects a rise of 11.84%.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the Aug 10, 2026, the price of an Novo Nordisk A/S (NVO) share was $47.73.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $64.16 and the 52-week low is $35.13.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the Aug 10, 2026, the market capitalization of Novo Nordisk A/S is 211.95B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is Nov 04, 2026.
Click to get the best stock tips daily for free!
ABOUT NOVO NORDISK A/S
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE